🔥🐔 BizChicken 🐔🔥

Companies Similar to MIRA Pharmaceuticals, Inc.

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Athira Pharma, Inc.

Athira Pharma, Inc. logo
Market Cap: Lowest
Employees: Low

ATH-1017

Athira Pharma, Inc. is a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, with its lead product, ATH-1017, in clinical trials for Alzheimer's and Parkinson's diseases.

Tags: Alzheimer's disease, Parkinson's disease, biopharmaceutical, clinical trials, neurodegeneration

Symbol: ATHA

Recent Price: $0.55

Industry: Biotechnology

CEO: Dr. Mark J. Litton M.B.A., Ph.D.

Sector: Healthcare

Employees: 65

Address: 18706 North Creek Parkway, Bothell, WA 98011

Phone: 425 620 8501

Last updated: 2024-12-31

ORIC Pharmaceuticals, Inc.

ORIC Pharmaceuticals, Inc. logo
Market Cap: Medium
Employees: Low

ORIC-533, ORIC-944, ORIC-114

ORIC Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that discovers and develops therapies for the treatment of cancers, focusing on overcoming resistance in chemotherapy and immunotherapy. Their product candidates target various cancer resistance mechanisms, including prostate cancer and epidermal growth factor receptor mutations.

Tags: ORIC-114, ORIC-533, ORIC-944, biopharmaceutical, cancer treatment, clinical-stage

Symbol: ORIC

Recent Price: $8.17

Industry: Biotechnology

CEO: Dr. Jacob M. Chacko M.B.A., M.D.

Sector: Healthcare

Employees: 107

Address: 240 East Grand Avenue, South San Francisco, CA 94080

Phone: 650 388 5600

Last updated: 2024-12-31

Omeros Corporation

Omeros Corporation logo
Market Cap: Low
Employees: Low

Narsoplimab

Omeros Corporation is a commercial-stage biopharmaceutical company that focuses on discovering, developing, and commercializing therapeutics for inflammation, immune-related cancers, and addictive disorders.

Tags: Narsoplimab, addiction, biopharmaceutical, clinical trials, drug development, immune system, therapeutics

Symbol: OMER

Recent Price: $9.74

Industry: Biotechnology

CEO: Dr. Gregory A. Demopulos M.D.

Sector: Healthcare

Employees: 198

Address: The Omeros Building, Seattle, WA 98119

Phone: 206 676 5000

Last updated: 2024-12-31

ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc. logo
Market Cap: Medium
Employees: Medium

Branded and generic prescription pharmaceuticals

ANI Pharmaceuticals, Inc. is a biopharmaceutical company that develops, manufactures, and markets branded and generic prescription pharmaceuticals, focusing on controlled substances, oncology products, hormones, steroids, injectables, and other formulations in the United States and Canada.

Tags: biopharmaceutical, controlled substances, hormones, injectables, oncology, prescription drugs, steroids

Symbol: ANIP

Recent Price: $54.87

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. Nikhil Lalwani

Sector: Healthcare

Employees: 642

Address: 210 Main Street West, Baudette, MN 56623

Phone: 218 634 3500

Last updated: 2024-12-31

Telomir Pharmaceuticals, Inc. Common Stock

Telomir Pharmaceuticals, Inc. Common Stock logo
Market Cap: Low
Employees: Lowest

TELOMIR-1

Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on developing and commercializing therapies for age-related inflammatory conditions and post-chemotherapy recovery.

Tags: TELOMIR-1, inflammatory conditions, pharmaceutical, stem cells, therapeutic treatment

Symbol: TELO

Recent Price: $4.64

Industry: Biotechnology

CEO: Mr. Erez Aminov

Sector: Healthcare

Employees: 1

Address: 855 N Wolfe Street, Baltimore, null 21205

Phone: (737)-289-0835

Last updated: 2024-12-31

Alto Neuroscience, Inc.

Alto Neuroscience, Inc. logo
Market Cap: Low
Employees: Low

ALTO-100, ALTO-300, ALTO-101, ALTO-203, ALTO-202

Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company specializing in psychiatry drug development, with a range of innovative treatments targeting major depressive disorder and cognitive impairments.

Tags: AI-enabled biomarker, MDD, biopharmaceutical, cognitive impairment, drug development, psychiatry, schizophrenia

Symbol: ANRO

Recent Price: $4.20

Industry: Biotechnology

CEO: Dr. Amit Etkin M.D., Ph.D.

Sector: Healthcare

Employees: 78

Address: 369 South San Antonio Road, Los Altos, CA 94022

Phone: (650) 200-0412

Last updated: 2024-12-31

Anebulo Pharmaceuticals, Inc.

Anebulo Pharmaceuticals, Inc. logo
Market Cap: Lowest
Employees: Lowest

ANEB-001

Anebulo Pharmaceuticals is a clinical-stage biotechnology company focused on developing and commercializing treatments for acute cannabinoid intoxication and substance addiction, including their lead product candidate ANEB-001.

Tags: ANEB-001, biotechnology, cannabinoid intoxication, clinical-stage, substance addiction

Symbol: ANEB

Recent Price: $1.64

Industry: Biotechnology

CEO: Mr. Richard Anthony Cunningham

Sector: Healthcare

Employees: 2

Address: 1415 Ranch Road 620 South, Lakeway, TX 78734

Phone: 512 598 0931

Last updated: 2024-12-31

Biora Therapeutics, Inc.

Biora Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

oral biotherapeutics

Biora Therapeutics, Inc., a biotechnology company, focuses on developing oral biotherapeutics using ingestible smart capsules for targeted delivery in the gastrointestinal tract and needle-free delivery into the intestinal mucosa.

Tags: GI diseases, biotechnology, diagnostics, inflammatory bowel diseases, oral biotherapeutics, systemic uptake

Symbol: BIOR

Recent Price: $0.22

Industry: Biotechnology

CEO: Mr. Aditya P. Mohanty M.B.A.

Sector: Healthcare

Employees: 58

Address: 4330 La Jolla Village Drive, San Diego, CA 92122

Phone: 855 293 2639

Leadership

  • Adi Mohanty, MBA, Chief Executive Officer & Board Member
  • Eric d’Esparbes, Chief Financial Officer
  • Robyn Hatton, Head of Human Resources
  • Ariella Kelman, MD, Chief Medical Officer
  • James Knight, MBA, Head of Business Development
  • Clarke Neumann, JD, General Counsel and Secretary
  • Paul Shabram, MBA, Head of Technical Operations
  • Sharat Singh, PhD, Head of Research
  • Maria (Mimi) Villanueva CPMI, PPMC, Vice President, Product Development Operations & Program Management
  • Jeffrey Alter, MBA, Board Chair
  • Jeffrey Ferrell, Board Member
  • Jill Howe, Board Member
  • Brian Kotzin, MD, Board Member
  • Lynne Powell, MBA, Board Member
  • Bruce Sands, MD, MS, Advisory Board Chair
  • Geert D’Haens, MD, PhD, Advisory Board Member
  • Brian Feagan, MD, FRCPC, Advisory Board Member
  • Séverine Vermeire, MD, PhD, Advisory Board Member
  • Satish Rao, MD, PhD, Advisory Board Chair
  • William Chey, MD, Advisory Board Member
  • Anthony Lembo, MD, Advisory Board Member
  • Mark Pimentel, MD, Advisory Board Member

Last updated: 2024-12-31

Biomerica, Inc.

Biomerica, Inc. logo
Market Cap: Lowest
Employees: Low

diagnostic and therapeutic products

Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures, and markets diagnostic and therapeutic products for medical conditions and diseases worldwide, focusing on gastrointestinal diseases, food intolerances, and diabetes.

Tags: biomedical, diabetes, diagnostic, food intolerances, gastrointestinal, therapeutic

Symbol: BMRA

Recent Price: $0.31

Industry: Medical - Devices

CEO: Mr. Zackary S. Irani

Sector: Healthcare

Employees: 64

Address: 17571 Von Karman Avenue, Irvine, CA 92614

Phone: 949 645 2111

Last updated: 2024-12-31

BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc. logo
Market Cap: Highest
Employees: High

Vimizim

Bio Marin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Their products cater to conditions like mucopolysaccharidosis, phenylketonuria, Batten disease, and more.

Tags: biotechnology, enzyme replacement therapy, healthcare, pharmaceutical, rare diseases

Symbol: BMRN

Recent Price: $65.45

Industry: Biotechnology

CEO: Mr. Alexander Hardy

Sector: Healthcare

Employees: 3401

Address: 770 Lindaro Street, San Rafael, CA 94901

Phone: 415 506 6700

Leadership

  • Mark Enyedy,
  • Alexander Hardy,
  • Elaine J. Heron,
  • G. Eric Davis, Executive Vice President, Chief Legal Officer
  • Greg Friberg, Executive Vice President, Chief Research & Development Officer
  • C. Greg Guyer, Executive Vice President, Chief Technical Officer
  • Cristin Hubbard, Executive Vice President, Chief Commercial Officer
  • Marni Kottle, Executive Vice President, Chief Corporate Affairs Officer
  • Brian R. Mueller, Executive Vice President, Chief Financial Officer
  • James Sabry, Executive Vice President, Chief Business Officer
  • Amy Wireman, Executive Vice President, Chief People Officer
  • Richard A. Meier,
  • Elizabeth McKee Anderson,
  • Barbara Bodem,
  • Athena Countouriotis,
  • Willard H. Dere,
  • Maykin Ho,
  • Robert J. Hombach,
  • David E.I. Pyott,

Last updated: 2024-12-31

Cognition Therapeutics, Inc.

Cognition Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

CT1812

Cognition Therapeutics is a clinical-stage biopharmaceutical company specializing in small molecule therapeutics for age-related degenerative diseases and central nervous system disorders. Its lead product, CT1812, is designed to treat Alzheimer's disease and dementia with Lewy bodies.

Tags: Alzheimer's disease, biopharmaceutical, central nervous system, retina disorders, small molecule therapeutics

Symbol: CGTX

Recent Price: $0.75

Industry: Biotechnology

CEO: Ms. Lisa Ricciardi

Sector: Healthcare

Employees: 25

Address: 2500 Westchester Avenue, Purchase, NY 10577

Phone: 412 481 2210

Leadership

  • Lisa Ricciardi, Chief Executive Officer​
  • Anthony C. Caggiano, M.D., Ph.D., Chief Medical Officer, Head of R&D
  • John Doyle, Chief Financial Officer
  • Anita Cornet, Head of Quality
  • Theresa Devins, DrPH, Vice President, Clinical Operations
  • Mary Hamby, Ph.D., Vice President, Research
  • Bobby Horn, Corporate Controller
  • Jennifer Iaci, Vice President, Development Operations
  • Steven A. Weissman, Ph.D., Vice President and Head of CMC
  • Jack A. Khattar, CEO
  • Aaron Fletcher, Ph.D.,
  • Brett P. Monia, Ph.D., CEO
  • Ellen B. Richstone,
  • Peggy Wallace,

Last updated: 2024-12-31

Enveric Biosciences, Inc.

Enveric Biosciences, Inc. logo
Market Cap: Lowest
Employees: Lowest

Cannabinoid Medicines

Enveric Biosciences, Inc. is a pharmaceutical company focused on developing cannabinoid medicines for cancer care, including treatments for osteoarthritis, cancer-related distress, mental health, and topical skin applications.

Tags: biotechnology, cancer care, cannabinoid medicines, mental health, pharmaceuticals

Symbol: ENVB

Recent Price: $0.33

Industry: Biotechnology

CEO: Dr. Joseph Edward Tucker Ph.D.

Sector: Healthcare

Employees: 7

Address: 4851 Tamiami Trail North, Naples, FL 34103

Phone: 239 302 1707

Last updated: 2024-12-31

Kiora Pharmaceuticals, Inc.

Kiora Pharmaceuticals, Inc. logo
Market Cap: Lowest
Employees: Lowest

KIO-301

Kiora Pharmaceuticals, Inc. develops therapies for ophthalmic diseases, with lead product KIO-301 in Phase 1 trial for vision restoration in degenerative retinal diseases and other products in trials for conditions like rheumatoid arthritis-related ocular issues and corneal wound repair.

Tags: clinical trials, ophthalmic diseases, ophthalmology, pharmaceuticals, vision restoration

Symbol: KPRX

Recent Price: $3.30

Industry: Biotechnology

CEO: Dr. Brian M. Strem Ph.D.

Sector: Healthcare

Employees: 12

Address: 1371 East 2100 South, Salt Lake City, UT 84105

Phone: 781 788 8869

Last updated: 2024-12-31

MIRA Pharmaceuticals, Inc.

MIRA Pharmaceuticals, Inc. logo
Market Cap: Lowest
Employees: Lowest

MIRA1a

MIRA Pharmaceuticals, Inc. is a clinical development stage biopharmaceutical company focusing on the development and commercialization of a new molecular synthetic THC analog for treating anxiety and cognitive decline associated with early-stage dementia.

Tags: MIRA1a, anxiety treatment, biopharmaceutical, cannabinoid receptors, cognitive decline, synthetic THC

Symbol: MIRA

Recent Price: $1.14

Industry: Drug Manufacturers - General

CEO: Mr. Erez Aminov

Sector: Healthcare

Employees: 2

Address: 855 North Wolfe Street, Baltimore, MD 21205

Phone: 737-289-0835

Leadership

  • Erez Aminov, Chairman of the Board and Chief Executive Officer
  • Itzchak Angel, PhD, Chief Scientific Advisor
  • Michelle Yanez, MBA, Chief Financial Officer, Secretary, and Treasurer
  • Matthew Del Giudice, MD, Director
  • Michael Jerman, Director
  • Ned Macpherson, Director
  • Denil N. Shekhat, MD, Director

Last updated: 2024-12-31

Mirum Pharmaceuticals, Inc.

Mirum Pharmaceuticals, Inc. logo
Market Cap: High
Employees: Low

LIVMARLI

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing novel therapies for rare and orphan diseases, with products like LIVMARLI and Volixibat.

Tags: LIVMARLI, Volixibat, biopharmaceutical, orphan diseases, rare diseases

Symbol: MIRM

Recent Price: $41.18

Industry: Biotechnology

CEO: Mr. Christopher Peetz

Sector: Healthcare

Employees: 294

Address: 950 Tower Lane, Foster City, CA 94404

Phone: 650 667 4085

Leadership

  • Chris Peetz, Chief Executive Officer, Mirum Pharmaceuticals
  • Erin Campany, Senior Vice President, Human Resources
  • Eric Bjerkholt, Chief Financial Officer
  • Jean-Luc Girardet, Ph.D., Senior Vice President, Technical Operations
  • Vinita Kumar, Senior Vice President, Quality
  • Lara Longpre, Chief Development Officer
  • Joanne Quan, M.D., Chief Medical Officer
  • Peter Radovich, President & Chief Operating Officer
  • Paul Ross, Chief Compliance Officer
  • Pamela Vig, Ph.D., Chief Scientific Officer and Head of Research
  • Laura Brege, Board Member
  • Patrick Heron, Managing General Partner, Frazier Healthcare Partners
  • Tim Walbert, Former Chairman, President and Chief Executive Officer, Horizon Therapeutics; Sr. Advisor, Amgen
  • Lon Cardon, Ph.D., FMedSci., Board Member
  • William C. Fairey, Board Member
  • Laurent Fischer, M.D., President & Chief Executive Officer, Adverum Biotechnologies
  • Mike Grey, Chairman of the Board, Mirum Pharmaceuticals
  • Saira Ramasastry, MS, MPhil, Managing Partner, Life Sciences Advisory, LLC

Last updated: 2024-12-31

Silo Pharma, Inc.

Silo Pharma, Inc. logo
Market Cap: Lowest
Employees: Lowest

SPC-15

Silo Pharma Inc. is a developmental stage biopharmaceutical company focusing on treatments for stress-induced psychiatric disorders, chronic pain, and CNS diseases through traditional and psychedelic therapies.

Tags: CNS diseases, biopharmaceutical, chronic pain, psychedelic treatments, psychiatric disorders, traditional therapies

Symbol: SILO

Recent Price: $0.89

Industry: Biotechnology

CEO: Mr. Eric Weisblum

Sector: Healthcare

Employees: 3

Address: 677 N. Washington Boulevard, Sarasota, FL 34236

Phone: 718 400 9031

Last updated: 2024-12-31

Protara Therapeutics, Inc.

Protara Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

N/A

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. The company was formerly known as ArTara Therapeutics, Inc. and changed its name to Protara Therapeutics, Inc. in May 2020. Protara Therapeutics, Inc. is headquartered in New York, New York.

No tags available.

Symbol: TARA

Recent Price: $5.28

Industry: Biotechnology

CEO: Mr. Jesse Shefferman

Sector: Healthcare

Employees: 26

Address: 345 Park Avenue South, New York, NY 10010

Phone: 646 844 0337

Last updated: 2024-12-31

Cencora

Cencora logo
Market Cap: Highest
Employees: Highest

pharmaceutical products

Cencora, Inc. sources and distributes pharmaceutical products, offering a range of services including pharmacy management, supply management software, packaging solutions, and clinical trial support to various healthcare providers and manufacturers.

Tags: clinical trial support, consulting services, data analytics, distribution, healthcare, pharmaceuticals, supply management

Symbol: COR

Recent Price: $224.71

Industry: Medical - Distribution

CEO: Dr. Robert P. Mauch Ph.D., PharmD

Sector: Healthcare

Employees: 46000

Address: 1 West First Avenue, Conshohocken, PA 19428

Phone: 610 727 7000

Last updated: 2024-12-31

MeiraGTx Holdings plc

MeiraGTx Holdings plc logo
Market Cap: Low
Employees: Medium

Gene Therapy Treatments

Meira GTx Holdings plc is a clinical stage gene therapy company developing treatments for serious diseases, including ocular diseases, xerostomia, and neurodegenerative conditions. They are in various stages of clinical development for several gene therapy programs and have a research collaboration with Janssen Pharmaceuticals.

Tags: Clinical Stage, Gene Therapy, Neurodegenerative Diseases, Ocular Diseases, Research Collaboration, Xerostomia

Symbol: MGTX

Recent Price: $5.89

Industry: Biotechnology

CEO: Dr. Alexandria Forbes Ph.D.

Sector: Healthcare

Employees: 387

Address: 430 East 29th Street, New York, NY 10016

Phone: 646 860 7985

Leadership

  • Alexandria Forbes, Ph.D., Board Member, President and Chief Executive Officer
  • Richard Giroux, Chief Operating Officer and Chief Financial Officer
  • Stuart Naylor, Ph.D., Chief Development Officer
  • Robert K. Zeldin, M.D., Chief Medical Officer
  • Robert Wollin, JD, General Counsel and Secretary
  • Alastair Leighton, Ph.D, SVP, Manufacturing and Supply Chain
  • Christine Sheehy, SVP, Global Integration
  • Tim Randall, SVP, Risk and Internal Controls
  • Michel Michaelides, M.D., Head of Clinical Ophthalmology
  • Tassos Georgiadis, Ph.D., Vice President, Preclinical Development
  • Keith R. Harris, Ph.D., Chairman of the Board
  • Ellen Hukkelhoven, Ph.D., Board Member
  • Lord Mendoza, Independent Board Member
  • Nicole Seligman, Independent Board Member
  • Thomas E. Shenk, Ph.D., Independent Board Member
  • Debra Yu, M.D., Independent Board Member

Last updated: 2024-12-31

Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals, Inc. logo
Market Cap: Medium
Employees: Low

TERN-101, TERN-201, TERN-501, TERN-601

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing small-molecule therapies for non-alcoholic steatohepatitis (NASH) and obesity, incorporating products like TERN-101, TERN-201, TERN-501, and TERN-601.

Tags: NASH, biopharmaceutical, clinical trials, obesity, pharmaceutical research

Symbol: TERN

Recent Price: $7.15

Industry: Biotechnology

CEO: Ms. Amy L. Burroughs M.B.A.

Sector: Healthcare

Employees: 66

Address: 1065 East Hillsdale Boulevard, Foster City, CA 94404

Phone: 650 525 5535

Last updated: 2024-11-08